These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7115434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. On the participation of cytochrome P-450 in the mechanism of prevention of hepatic carcinogenesis.
    Saprin AN.
    Adv Exp Med Biol; 1976; 74():314-20. PubMed ID: 183471
    [No Abstract] [Full Text] [Related]

  • 8. Evidence that ligand formation is a mechanism underlying the maintenance of cytochrome P-450 in rat liver cell culture. Potent maintenance by metyrapone.
    Paine AJ, Villa P, Hockin LJ.
    Biochem J; 1980 Jun 15; 188(3):937-9. PubMed ID: 7470047
    [Abstract] [Full Text] [Related]

  • 9. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP, Kunke S, Netter KJ.
    Biochem Pharmacol; 1974 Sep 15; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of underfeeding suckling rats on the activity of hepatic drug metabolizing enzymes.
    Basu TK, Dickerson JW, Parke DV.
    Biol Neonate; 1973 Sep 15; 23(1):109-15. PubMed ID: 4773512
    [No Abstract] [Full Text] [Related]

  • 13. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
    Wright MC, Wang XJ, Pimenta M, Ribeiro V, Paine AJ, Lechner MC.
    Mol Pharmacol; 1996 Oct 15; 50(4):856-63. PubMed ID: 8863830
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of hepatic cytochrome P-450-dependent mono-oxygenase systems.
    Gander JE, Mannering GJ.
    Pharmacol Ther; 1980 Oct 15; 10(2):191-221. PubMed ID: 6997897
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of effects of dietary administration of butylated hydroxytoluene or a polymeric antioxidant on the hepatic and intestinal cytochrome P-450 mixed-function-oxygenase system of rats.
    Halladay SC, Ryerson BA, Smith CR, Brown JP, Parkinson TM.
    Food Cosmet Toxicol; 1980 Dec 15; 18(6):569-74. PubMed ID: 7203304
    [No Abstract] [Full Text] [Related]

  • 16. Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus.
    Renton KW.
    Biochem Pharmacol; 1981 Aug 15; 30(16):2333-6. PubMed ID: 6271141
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhanced activity of liver drug-metabolizing enzymes for aromatic and chlorinated hydrocarbons following food deprivation.
    Nakajima T, Sato A.
    Toxicol Appl Pharmacol; 1979 Sep 30; 50(3):549-56. PubMed ID: 516066
    [No Abstract] [Full Text] [Related]

  • 19. Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
    Bickers DR, Dutta-Choudhury T, Mukhtar H.
    Mol Pharmacol; 1982 Jan 30; 21(1):239-47. PubMed ID: 7132961
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.